Efficacy of concomitant and adjuvant temozolomide in glioblastoma treatment. A multicentre randomized study

Abstract

The introduction of TMZ before, during and after radiotherapy for newly diagnosed glioblastoma multiforme gives clinically and statistically significant improvement of survival with unremarkably increased toxicity of the treatment.